This hypothesis was tested by examining postmortem cases of advanced AD and detecting abnormal expressions of genes encoding insulin, as well as IGF peptides and their receptors [83], that correlated with the development and progression of lesions and dementia. The gene discussed is INS; the disease is Alzheimer disease.